EGFR tyrosine kinase inhibitors versus chemotherapy in EGFR wild-type pre-treated advanced nonsmall cell lung cancer in daily practice - Aix-Marseille Université
Article Dans Une Revue European Respiratory Journal Année : 2017

EGFR tyrosine kinase inhibitors versus chemotherapy in EGFR wild-type pre-treated advanced nonsmall cell lung cancer in daily practice

Marie Wislez

Domaines

Cancer

Dates et versions

hal-01699297 , version 1 (02-02-2018)

Identifiants

Citer

Pascale Tomasini, Solenn Brosseau, Julien Mazières, Jean Merlio, Michèle Beau-Faller, et al.. EGFR tyrosine kinase inhibitors versus chemotherapy in EGFR wild-type pre-treated advanced nonsmall cell lung cancer in daily practice. European Respiratory Journal, 2017, 50 (2), pii: 1700514. ⟨10.1183/13993003.00514-2017⟩. ⟨hal-01699297⟩
231 Consultations
0 Téléchargements

Altmetric

Partager

More